Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes

Continuous subcutaneous insulin infusion (CSII) treatment may improve long-term glycemic outcomes and enhance quality of life compared with a multiple daily injection (MDI) insulin regimen for people with type 1 diabetes. As the number of people treated with CSII via a tubeless insulin pump is incre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Diabetes
Main Authors: Mehta, Sanjeev N., Tinsley, Liane J., Kruger, Davida, Bode, Bruce, Layne, Jennifer E., Huyett, Lauren M., Dryga, Kate, Dumais, Bonnie, Ly, Trang T., Laffel, Lori M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2021
Assuntos:
Feature Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839599/
https://ncbi.nlm.nih.gov/pubmed/33551556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/cd20-0022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados